Suchergebnisse - "Huang, Le"

PubPharm (7)

1

Is neoadjuvant immunotherapy necessary in patients with programmed death ligand 1 expression-negative resectable non-small cell lung cancer? A systematic review and meta-analysis

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Zhang, S. | Tian, Y. | Yu, J. | +5

2

Impact of EGFR exon 19 deletion subtypes on clinical outcomes in EGFR-TKI-Treated advanced non-small-cell lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2022

von Huang, L. | Zhang, S. | Han, C. | +1

3

Efficacy and safety of recombinant human endostatin combined with radiotherapy or chemoradiotherapy in patients with locally advanced non-small cell lung cancer : a pooled analysis

enthalten in: Radiation oncology (London, England) | 2020

von Zhang, S. | Han, C. | Sun, L. | +2

4

Efficacy and safety of recombinant human endostatin combined with radiotherapy or chemoradiotherapy in patients with locally advanced non-small cell lung cancer: a pooled analysis

enthalten in: Radiation oncology | 2020

von Zhang, S. | Han, C. | Sun, L. | +2

5

Efficacy and safety of recombinant human endostatin combined with radiotherapy or chemoradiotherapy in patients with locally advanced non-small cell lung cancer: a pooled analysis

enthalten in: Radiation oncology | 2020

von Zhang, S. | Han, C. | Sun, L. | +2

6

Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?

enthalten in: Radiation oncology (London, England) | 2017

von Ma, J. | Sun, L. | Sun, X. | +5

7

Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?

enthalten in: Radiation oncology | 2017

von Ma, J. | Sun, L. | Sun, X. | +5

1
[1]